Ophthalmic Devices

FDA Has Announced That Ocular Therapeutix Obtained Favorable Votes for Resure Sealant
Sep 24, 2013
The US Food and Drug Administration’s (FDA) Ophthalmic Devices Panel announced that Ocular Therapeutix’s ReSure sealant is safe and effective in managing clear corneal wound leaks following cataract surgery. ReSure Sealant is ...

Tags: Ocular Therapeutix, Medicine
US FDA Panel Decide on Ocular Premarket Approval Application for The Resure Sealant
Aug 12, 2013
The US Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel is scheduled to decide on Ocular Therapeutix’s premarket approval application for the ReSure Sealant in September and may suggest some recommendations. ...

Tags: Ophthalmic Devices, Health
The Argus II System Is Used in Patients with Severe to Profound Retinitis Pigmentosa
Dec 18, 2012
The Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel has scheduled to review the data presented in the Second Sight Medical Products' humanitarian device exemption (HDE) market approval application, for its Argus II ...

Tags: FDA, Argus II System, medical technology